Progyny (PGNY) Shares Outstanding (Weighted Average) (2018 - 2026)

Progyny (PGNY) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $80.9 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $80.9 million, down 5.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $80.9 million (down 5.35% YoY), and the FY2025 annual result was $85.2 million, down 6.83% from the prior year.
• Shares Outstanding (Weighted Average) declined to $80.9 million in Q1 2026 per PGNY's latest filing, from $85.2 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $96.5 million in Q1 2024 and troughed at $80.9 million in Q1 2026.
• A 5-year average of $90.7 million and a median of $92.0 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) rose 4.58% in 2022, then decreased 11.39% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $92.2 million in 2022, then climbed by 3.07% to $95.0 million in 2023, then decreased by 3.72% to $91.5 million in 2024, then declined by 6.83% to $85.2 million in 2025, then decreased by 5.06% to $80.9 million in 2026.
• Business Quant data shows PGNY's Shares Outstanding (Weighted Average) at $80.9 million in Q1 2026, $85.2 million in Q4 2025, and $86.0 million in Q3 2025.